The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.
Year: 2016
Type: article
Abstract: Dp44mT showed a significant reduction in the 143B xenograft tumor growth and metastasis. In conclusion, our data demonstrated that Dp44mT has effective anticancer capability in osteosarcoma and that may represent a promising treatment strategy for osteosarcoma.
Source: PubMed
Authors: Pengcheng Li, Xun Zheng, Kangquan Shou, Yahui Niu, Chao Jian, Yong Zhao, Wanrong Yi, Xiang Hu, Aixi Yu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3021502711
